View PDF ↗
PDF Viewer
Open Full PDF

BUILDER'S SANDBOX

Build This Paper

Use an AI coding agent to implement this research.

OpenAI Codex
OpenAI CodexAI Agent

Lightweight coding agent in your terminal.

Claude Code
Claude CodeAI Agent

Agentic coding tool for terminal workflows.

AntiGravity IDE
AntiGravity IDEScaffolding

AI agent mindset installer and workflow scaffolder.

Cursor
CursorIDE

AI-first code editor built on VS Code.

VS Code
VS CodeIDE

Free, open-source editor by Microsoft.

MVP Investment

$9K - $12K
6-10 weeks
Engineering
$8,000
Cloud Hosting
$240
SaaS Stack
$300
Domain & Legal
$100

6mo ROI

2-4x

3yr ROI

10-20x

Lightweight AI tools can reach profitability quickly. At $500/mo average contract, 20 customers = $10K MRR by 6mo, 200+ by 3yr.

Talent Scout

S

Sepehr Salem Ghahfarokhi

Georgia State University

M

Mohammed Alser

Georgia State University

M

M. Moein Esfahani

Georgia State University

R

Raj Sunderraman

Georgia State University

Find Similar Experts

Medical experts on LinkedIn & GitHub

References (20)

[1]
Breast Cancer Detection in Thermographic Images via Diffusion-Based Augmentation and Nonlinear Feature Fusion
2025S. Salem, M. M. Esfahani et al.
[2]
Lightweight convolutional neural networks using nonlinear Lévy chaotic moth flame optimisation for brain tumour classification via efficient hyperparameter tuning
2025Amin Abdollahi Dehkordi, Mehdi Neshat et al.
[3]
Brain tumor detection empowered with ensemble deep learning approaches from MRI scan images
2025Rizwana Naz Asif, Muhammad Tahir Naseem et al.
[4]
Automatic Generation of Brain Tumor Diagnostic Reports from Multimodality MRI Using Large Language Models
2025Essam A. Rashed, Walayat Hussain et al.
[5]
CDCG-UNet: Chaotic Optimization Assisted Brain Tumor Segmentation Based on Dilated Channel Gate Attention U-Net Model
2025K. Bhagyalaxmi, B. Dwarakanath
[6]
Neuro-XAI: Explainable Deep Learning Framework based on DeeplabV3+ and Bayesian Optimization for Segmentation and Classification of Brain Tumor in MRI Scans.
2024Tallha Saeed, Muhammad Attique Khan et al.
[7]
An XAI-Enhanced EfficientNetB0 Framework for Precision Brain Tumor Detection in MRI Imaging.
2024M. T R, Muskan Gupta et al.
[8]
Estimation of Fractal Dimension and Segmentation of Brain Tumor with Parallel Features Aggregation Network
2024Haseeb Sultan, Nadeem Ullah et al.
[9]
Fractal dimension: analyzing its potential as a neuroimaging biomarker for brain tumor diagnosis using machine learning
2023Dheerendranath Battalapalli, Sreejith Vidyadharan et al.
[10]
Computational Modeling of Deep Multiresolution-Fractal Texture and Its Application to Abnormal Brain Tissue Segmentation
2023A. Temtam, L. Pei et al.
[11]
Malignant melanoma diagnosis applying a machine learning method based on the combination of nonlinear and texture features
2023S. S. Ghahfarrokhi, H. Khodadadi et al.
[12]
medXGAN: Visual Explanations for Medical Classifiers through a Generative Latent Space
2022Amil Dravid, Florian Schiffers et al.
[13]
EANO guideline on the diagnosis and management of meningiomas.
2021R. Goldbrunner, P. Stavrinou et al.
[14]
Human brain tumor diagnosis using the combination of the complexity measures and texture features through magnetic resonance image
2020S. S. Ghahfarrokhi, H. Khodadadi
[15]
Brain tumor classification using deep CNN features via transfer learning
2019S. Deepak, P. M. Ameer
[16]
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2018C. Rudin
[17]
A survey on deep learning in medical image analysis
2017G. Litjens, Thijs Kooi et al.
[18]
brain tumor dataset
2016Jun Cheng
[19]
Deep Residual Learning for Image Recognition
2015Kaiming He, X. Zhang et al.
[20]
Brain tumor segmentation with Deep Neural Networks
2015Mohammad Havaei, Axel Davy et al.

Founder's Pitch

"XMorph provides an explainable AI solution for brain tumor diagnosis with superior accuracy and clinical acceptance."

Medical ImagingScore: 8View PDF ↗

Commercial Viability Breakdown

0-10 scale

High Potential

2/4 signals

5

Quick Build

4/4 signals

10

Series A Potential

4/4 signals

10

Sources used for this analysis

arXiv Paper

Full-text PDF analysis of the research paper

GitHub Repository

Code availability, stars, and contributor activity

Citation Network

Semantic Scholar citations and co-citation patterns

Community Predictions

Crowd-sourced unicorn probability assessments

Analysis model: GPT-4o · Last scored: 2/24/2026

🔭 Research Neighborhood

Generating constellation...

~3-8 seconds

Why It Matters

The lack of interpretability and high computational demands are major barriers in AI-driven brain tumor diagnosis. XMorph promises not only high accuracy but also an explainable system that assures clinicians of its reliability, paving the way for wider clinical adoption.

Product Angle

Package XMorph as a standalone diagnostic software tool for medical imaging departments, or integrate it into existing MRI diagnostic equipment as a plug-in module.

Disruption

XMorph can replace traditional 'black box' AI models in medical imaging that do not provide interpretable results, gaining preference over existing solutions due to its transparency and efficiency.

Product Opportunity

The brain tumor diagnostic AI market is growing, with hospitals and imaging centers seeking reliable and interpretable AI solutions to improve diagnostic accuracy and efficiency.

Use Case Idea

Develop an AI software used in hospitals for diagnosing brain tumors with high accuracy and explainable outputs that doctors can trust for clinical decisions.

Science

XMorph utilizes a combination of deep learning and nonlinear dynamic features to improve brain tumor classification. It enhances boundaries using Information-Weighted Boundary Normalization and provides a dual-channel explainability module to produce visual and text descriptions of AI decisions.

Method & Eval

XMorph was evaluated against state-of-the-art models, achieving 96% accuracy with lower computational power requirements. The dual-channel explainability module was tested for providing interpretable insights.

Caveats

Potential issues include the need for integration with existing healthcare systems, continuous validation in diverse clinical settings, and reliance on the accuracy of initial tumor segmentation.

Author Intelligence

Sepehr Salem Ghahfarokhi

LEAD
Georgia State University
ssalemghahfarokhi1@gsu.edu

Mohammed Alser

LEAD
Georgia State University
malser@gsu.edu

M. Moein Esfahani

Georgia State University

Raj Sunderraman

Georgia State University

Vince Calhoun

TRenDS Center, Georgia State University